Compound: Navitoclax

Drug Target: BCL2, BCL-XL, BCL-W

Drug Target pathway: Apoptosis regulation

Dataset



Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.